38385077|t|Polyphenols Targeting NF-kappaB Pathway in Neurological Disorders: What We Know So Far?
38385077|a|Polyphenolic compounds have shown promising neuroprotective properties, making them a valuable resource for identifying prospective drug candidates to treat several neurological disorders (NDs). Numerous studies have reported that polyphenols can disrupt the nuclear factor kappa B(NF-kappaB) pathway by inhibiting the phosphorylation or ubiquitination of signaling molecules, which further prevents the degradation of IkappaB. Additionally, they prevent NF-kappaB translocation to the nucleus and pro-inflammatory cytokine production. Polyphenols such as curcumin, resveratrol, and pterostilbene had significant inhibitory effects on NF-kappaB, making them promising candidates for treating NDs. Recent experimental findings suggest that polyphenols possess a wide range of pharmacological properties. Notably, much attention has been directed towards their potential therapeutic effects in NDs such as Alzheimer's disease (AD), Parkinson's disease (PD), cerebral ischemia, anxiety, depression, autism, and spinal cord injury (SCI). Much preclinical data supporting the neurotherapeutic benefits of polyphenols has been developed. Nevertheless, this study has described the significance of polyphenols as potential neurotherapeutic agents, specifically emphasizing their impact on the NF-kappaB pathway. This article offers a comprehensive analysis of the involvement of polyphenols in NDs, including both preclinical and clinical perspectives.
38385077	0	11	Polyphenols	Chemical	MESH:D059808
38385077	22	31	NF-kappaB	Gene	4790
38385077	43	65	Neurological Disorders	Disease	MESH:D009461
38385077	88	110	Polyphenolic compounds	Chemical	-
38385077	253	275	neurological disorders	Disease	MESH:D009461
38385077	277	280	NDs	Disease	MESH:D009461
38385077	319	330	polyphenols	Chemical	MESH:D059808
38385077	370	379	NF-kappaB	Gene	4790
38385077	543	552	NF-kappaB	Gene	4790
38385077	590	602	inflammatory	Disease	MESH:D007249
38385077	624	635	Polyphenols	Chemical	MESH:D059808
38385077	644	652	curcumin	Chemical	MESH:D003474
38385077	654	665	resveratrol	Chemical	MESH:D000077185
38385077	671	684	pterostilbene	Chemical	MESH:C107773
38385077	723	732	NF-kappaB	Gene	4790
38385077	780	783	NDs	Disease	MESH:D009461
38385077	827	838	polyphenols	Chemical	MESH:D059808
38385077	980	983	NDs	Disease	MESH:D009461
38385077	992	1011	Alzheimer's disease	Disease	MESH:D000544
38385077	1013	1015	AD	Disease	MESH:D000544
38385077	1018	1037	Parkinson's disease	Disease	MESH:D010300
38385077	1039	1041	PD	Disease	MESH:D010300
38385077	1044	1061	cerebral ischemia	Disease	MESH:D002545
38385077	1063	1070	anxiety	Disease	MESH:D001007
38385077	1072	1082	depression	Disease	MESH:D003866
38385077	1084	1090	autism	Disease	MESH:D001321
38385077	1096	1114	spinal cord injury	Disease	MESH:D013119
38385077	1116	1119	SCI	Disease	MESH:D013119
38385077	1188	1199	polyphenols	Chemical	MESH:D059808
38385077	1279	1290	polyphenols	Chemical	MESH:D059808
38385077	1374	1383	NF-kappaB	Gene	4790
38385077	1460	1471	polyphenols	Chemical	MESH:D059808
38385077	1475	1478	NDs	Disease	MESH:D009461
38385077	Negative_Correlation	MESH:D059808	MESH:D009461
38385077	Negative_Correlation	MESH:D003474	MESH:D009461
38385077	Negative_Correlation	MESH:D000077185	MESH:D009461
38385077	Negative_Correlation	MESH:D003474	4790
38385077	Negative_Correlation	MESH:D059808	MESH:D002545
38385077	Negative_Correlation	MESH:D059808	MESH:D003866
38385077	Negative_Correlation	MESH:D059808	MESH:D001007
38385077	Negative_Correlation	MESH:C107773	4790
38385077	Association	MESH:D009461	4790
38385077	Negative_Correlation	MESH:D059808	MESH:D000544
38385077	Negative_Correlation	MESH:D059808	MESH:D001321
38385077	Negative_Correlation	MESH:D059808	MESH:D010300
38385077	Negative_Correlation	MESH:D059808	MESH:D013119
38385077	Negative_Correlation	MESH:D000077185	4790
38385077	Negative_Correlation	MESH:C107773	MESH:D009461
38385077	Negative_Correlation	MESH:D059808	4790
38385077	Negative_Correlation	MESH:D059808	MESH:D007249

